Stalfort John A III
CIK 0001709418
Director
Filings
10
Latest Jun 2, 2026
Issuers covered
3
Showing
10 of 10
Page 1
Track record
3 of 3 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 3 | 67% | +37.2% | +70.5% | +70.5% | -29.2% |
| 90 days | 3 | 0% | -29.2% | -31.1% | -25.4% | -31.1% |
| 180 days | 3 | 0% | -20.3% | -12.4% | -12.4% | -36.0% |
| 365 days | 3 | 67% | -5.1% | +18.7% | +18.7% | -52.6% |
Issuers
Companies where Stalfort John A III has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| TSHA | Taysha Gene Therapies, Inc. | 5 | Jun 2, 2026 |
| ABOS | Acumen Pharmaceuticals, Inc. | 4 | Jun 5, 2025 |
| VRCA | Verrica Pharmaceuticals Inc. | 1 | Nov 26, 2024 |
All filings
10 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|